What is semantic harmonization in drug discovery and development?

Semantic harmonization is the process of creating a shared layer of meaning across fragmented biomedical data sources. It connects different data formats, terminology, concepts, and relationships so researchers and AI systems can interpret and reason across data consistently.

Why is semantic harmonization important for AI-native R&D?

Semantic harmonization provides AI-native R&D systems with the context needed to understand fragmented biomedical data. By connecting information across research, preclinical, clinical, and regulatory sources, it helps AI systems and researchers work with data that would otherwise remain difficult to interpret across disconnected systems.

What is a semantic layer in biomedical research?

A semantic layer is a machine-interpretable layer of meaning placed over existing biomedical databases, laboratory systems, and operational processes. It can use ontologies, knowledge graphs, and natural language understanding to connect fragmented data without requiring organizations to replace their existing infrastructure.

How do knowledge graphs support drug discovery?

Knowledge graphs connect relationships between biomedical concepts such as genes, targets, compounds, phenotypes, diseases, and experimental results. This allows researchers and AI systems to discover and reason over relationships across genomic, transcriptomic, proteomic, preclinical, and clinical datasets.

What role do ontologies play in AI-native drug development?

Ontologies provide standardized concepts and relationships that allow different biomedical datasets and systems to share a common vocabulary. They can help establish consistent meanings for concepts such as diseases, biomarkers, endpoints, adverse events, study types, and treatments.

How can semantic technologies make unstructured biomedical data useful for AI?

Semantic technologies such as natural language understanding, ontologies, and knowledge graphs can extract meaningful information from clinical notes, pathology reports, investigator comments, lab notebooks, adverse-event narratives, and regulatory documents. This can make previously difficult-to-query information more accessible to AI systems and researchers.

How can semantic harmonization support clinical trial data interpretation?

Semantic harmonization can align clinical data around shared definitions for endpoints, biomarkers, adverse events, laboratory results, imaging findings, and other research concepts. This can help researchers and AI systems interpret information consistently across different clinical data sources.

Why is a federated semantic layer useful for rare and orphan disease research?

Rare and orphan disease research often relies on evidence distributed across institutions, patient registries, case reports, and natural history studies. A federated semantic layer can connect these fragmented sources and enable researchers and AI systems to reason across them without requiring all data to be centralized in one repository.

How does semantic layering support AI-native R&D?

Semantic layering connects fragmented data sources through shared meaning and context, allowing foundation models, predictive models, autonomous laboratories, and researchers to reason across existing R&D systems. It provides a way to work with existing infrastructure without requiring every underlying system to be replaced.

How can semantic technologies support regulatory and safety decision-making?

Semantic technologies can connect regulatory, preclinical, and clinical evidence through shared concepts and traceable relationships. This can help researchers and AI systems reconstruct how evidence supports a benefit-risk assessment and provide clearer traceability from data to decisions.